Skip to main content
The Newport Daily Express
Click for weather forecast
Place a Classified Ad
View Full List
Streaming Delayed Price
Updated: 3:58 PM EDT, May 20, 2022
Add to My Watchlist
Headline News about Cytodyn Inc
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
March 31, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
February 14, 2022
Photo from Jason Briscoe on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
December 29, 2021
Pfizer (NYSE: PFE) is arguably one of the biggest leaders in COVID-19 technology, whether it’s their vaccine or their newly approved oral antiviral called Paxlovid. The...
These OTC Markets Securities had the Most Trading Activity in September
October 12, 2021
Photo by Annie Spratt on Unsplash As the 3rd quarter came to a close in September, the OTC Markets saw a slight decrease in total trading volume even as companies reported...
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...
OTC Markets Hits Major Milestones in Mid-Year Along With Big Volume and Gaining Securities
July 28, 2021
Photo by Kyrie Kim on Unsplash In a similar vein to 2020, the market’s volatility to start 2021 gave way to less volatility in the second quarter, and even less volatility...
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
What's Behind This Wild-Card Coronavirus Stock?
June 08, 2021
Failure is not an option for this small-cap biotech developing a COVID-19 treatment.
The Motley Fool
CytoDyn Plans To Send Topline Data From COVID-19 Trial Of Leronlimab To Regulators In India, Philippines
May 18, 2021
After facing rebuke from FDA, CytoDyn Inc (OTC: CYDY) plans to submit the topline results of its CD12 Phase 3 trial of Vyrologix (leronlimab-PRO 140...
CytoDyn Stock Falls After FDA Rebukes Claims On COVID-19 Treatment
May 18, 2021
The FDA has accused CytoDyn Inc (OTC: CYDY) of trying to pick and choose data from two failed studies of leronlimab in COVID-19 patients to claim the drug is...
These OTC Securities Had the Most Trading Activity in April
May 12, 2021
April was another fascinating month in OTC Markets trading, as cryptocurrency, internatio...
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
May 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...
Review Of Present Therapies For Covid-19
May 09, 2021
A summary of authorized drugs for Covid-19, those in development, and those that have failed.
Why Auris Medical, CytoDyn and Prometheus Shares Are Moving Today
April 08, 2021
Auris Medical Holding Ltd. (NASDAQ: EARS), CytoDyn Inc. (OTC: CYDY) and Prometheus Biosciences, Inc. (NASDAQ: RXDX) are among the biggest movers in the biopharma space Thursday....
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Terms and Conditions
Copyright © 2015 The Newport Daily Express | 178 Hill Street, P.O. Box 347 | Newport, VT 05855 | (802) 334-6568
All property rights for the entire contents of this publication shall be the property of The Newport Daily Express.
No part hereof may be reproduced without prior written consent.
Request new password